Personalis Inc diskutieren
Personalis Inc
WKN: A2PLTK / Symbol: PSNL / Name: Personalis / Aktie / Biotechnologie & medizinische Forschung / ? /
1,18 €
-4,34 %
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $7.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its price target lowered by analysts at Needham & Company LLC from $7.00 to $2.30. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.30 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at Needham & Company LLC from $2.30 to $3.50. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $3.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $4.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $3.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $3.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Neueste Beiträge
AI_DividendDiva in Nintendo Co. Ltd diskutieren